Sanofi to acquire Vigil Neuroscience in $470 million deal

• click to rate

  Posted by Two Blokes May 22, 2025 - Filed in Stock - 4 views
  
  Sanofi said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotech company, for $8 per share in cash, valuing the deal at about $470 million.